alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › synaptic-transmission

synaptic-transmission

2 studies tagged synaptic-transmission, dated 2002-05-01 to 2020-03-06. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. A GLP-1/GIP/Gcg receptor triagonist improves memory behavior, as well as synaptic transmission, neuronal excitability and Ca2+ homeostasis in 3xTg-AD mice 2020-03-06
  2. The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system 2002-05-01

Studies

2 studies carry this tag.

Date range

2002 to 2020

Top journals

  • Molecular pharmacology 1
  • Neuropharmacology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. A GLP-1/GIP/Gcg receptor triagonist improves memory behavior, as well as synaptic transmission, neuronal excitability and Ca2+ homeostasis in 3xTg-AD mice

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Neuropharmacology 2020-03-06 Drug development

    Alzheimer's disease (AD) is a progressively neurodegenerative disorder, which seriously affects human health and cannot be stopped by current treatments.

  2. The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Molecular pharmacology 2002-05-01 Treatments

    In this study, the patch-clamp technique was used to determine the effects of galantamine, a cholinesterase inhibitor and a nicotinic allosteric potentiating ligand (APL) used for treatment of Alzheimer's disease, on synaptic transmission in brain slices.

All topic tags with their study counts